Skip to main content
. 2019 Dec 30;15(4):397–415. doi: 10.1016/j.ajps.2019.11.004

Fig. 7.

Fig 7

Preparation of PM-NP-DOX, evaluation of tumor-specific targeting ability, and inhibition of tumor growth. (A) MSC membrane-shrouded polymeric PLGA nanoplatform for tumor-specific DOX delivery. (B) Tumor-specific targeting capability between lipo-NP and PM-NP groups. (C) Tumor inhibition efficacy after different treatments. PM: cell plasma membrane. Reproduced with permission from [112]. Copyright 2018 American Chemical Society.